Catalogo dei prodotti della ricerca

GUGLIELMI, Cesare
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.800
EU - Europa 564
AS - Asia 272
SA - Sud America 17
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.658
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.777
SE - Svezia 175
IN - India 128
IT - Italia 114
UA - Ucraina 111
SG - Singapore 82
FI - Finlandia 65
CN - Cina 56
DE - Germania 35
RO - Romania 24
CA - Canada 23
AR - Argentina 13
GB - Regno Unito 13
IE - Irlanda 11
BE - Belgio 4
BG - Bulgaria 4
GR - Grecia 4
BR - Brasile 3
JP - Giappone 3
AT - Austria 2
CH - Svizzera 2
HK - Hong Kong 2
TG - Togo 2
CL - Cile 1
EU - Europa 1
NZ - Nuova Zelanda 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 2.658
Salva come PNG Salva come JPEG
Città #
Fairfield 215
Chandler 183
Houston 152
Woodbridge 133
Ashburn 113
Wilmington 97
Princeton 85
Seattle 79
Cambridge 66
Plano 65
Ann Arbor 58
Des Moines 51
Boston 50
Singapore 42
Jacksonville 40
Dearborn 39
Rome 39
Beijing 35
Lawrence 35
San Paolo di Civitate 33
San Diego 22
Millbury 21
Andover 19
Falls Church 14
Bremen 13
Federal 13
Ottawa 13
Norwalk 12
Dublin 11
Boardman 10
Nanjing 8
Toronto 8
Hefei 6
Aprilia 5
Mannheim 5
Southend 5
Brussels 4
Buffalo 4
Cosenza 4
Nettuno 4
Sofia 4
Bühl 3
Madison 3
Redmond 3
San Mateo 3
Trumbull 3
Arnsberg 2
Bari 2
Bern 2
Bisceglie 2
Forno Canavese 2
Giarre 2
Grafing 2
Helsinki 2
Hong Kong 2
Karatsu 2
Lomé 2
Montréal 2
Munich 2
Nutley 2
Ribeirão Preto 2
Vienna 2
Ancona 1
Arezzo 1
Auckland 1
Broomfield 1
Caserta 1
Cecina 1
Chicago 1
Civitanova Marche 1
Civitavecchia 1
Crawley 1
Felixstowe 1
Forest City 1
Frankfurt am Main 1
Frontone 1
Fuzhou 1
Gandhi Nagar 1
Hangzhou 1
Istanbul 1
Jinan 1
Komatsubaradori 1
Kunming 1
La Spezia 1
Latina 1
Laurel 1
London 1
Muizenberg 1
Nanchang 1
Napoli 1
Portland 1
Potters Bar 1
Prineville 1
Provo 1
Redditch 1
Rho 1
Santiago 1
Shanghai 1
Shenyang 1
Simi Valley 1
Totale 1.900
Salva come PNG Salva come JPEG
Nome #
Outcome of patients developing GvHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT 76
Flt3L induces the ex vivo amplification of umbilical cord blood committed progenitors and early stem cells in short term cultures. 73
Immunophenotype of adult and childhood acute lymphoblastic leukemia: changes at first relapse and clinico-prognostic implications 73
p53 expression in B-cell chronic lymphocytic leukemia: A marker of disease progression and poor prognosis 68
Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplant: May We Predict Graft vs Leukemia without Graft vs Host Disease? 66
pathogenetic and clinical implications of bcl-6 and bcl-2 gene configuration in nodal diffuse large B-cell lymphomas 66
Follicular lymphoma international prognostic index 63
Secondary acute non lymphoid leukemia in patients treated for non Hodgkin's lymphoma: No risk of therapy-related ANLL after PROVECIP schedule 61
F-MACHOP IN ADVANCED AGGRESSIVE LYMPHOMA 60
Donor Lymphocyte Infusions from Unrelated Donors for Treatment of Relapsed Chronic Myelogenous Leukemia: Importance of Initial Cell Dose. 60
Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimens. 60
Donor lymphocyte infusions for chronic myeloid leukemia relapsing after allogeneic stem cell transplantation. may we predict graft-versus-leukemia without graft-versus-host disease? 59
Peripheral T cell lymphoma in adults: Morphological and phenotypical study of four cases 59
Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) 58
Iatrogenic EBV-positive lymphoproliferative disorder with features of EBV+ mucocutaneous ulcer: Evidence for concomitant TCRγ/IGH rearrangements in the Hodgkin-like neoplastic cells 57
Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation 57
Outcome of Patients Developing GVHD after DLI for CML Relapse from HLA-Identical Sibling or VUD HSCT. 56
Sequential combination chemotherapy of high-grade non-Hodgkin's lymphoma with 5-fluorouracil, methotrexate, cytosine-arabinoside, cyclophosphamide, doxorubicin, vincristine, and prednisone (F-MACHOP) 56
Donor Lymphocyte Transfusion (DLT) in the Treatment of Relapsed CML after Allogeneic PBSCT - A Retrospective Analysis of 346 Patients by the EBMT Chronic Leukemia Working Party. 52
Prognostic value of the histologic classification of peripheral T-cell lymphoma: a clinico-pathologic study of 71 HTLV-1 negative cases. 51
Heterogeneity of TdT+, HLA-DR+ acute leukaemia: immunological, immunocytochemical and clinical evidence of lymphoid and myeloid origin. 50
Acute lymphoblastic leukemia (ALL) primary refractory or in first relapse: results in children and adults over a 20-year period. 49
S-100+ lymph node neoplasm. Report of a case with histological AL and immunological features intermediate between T cell lymphoma and malignant histiocytosis. 49
Peripherally Inserted Central Catheter (PICC) Power Groshong 5 Fr device for management of peripheral blood stem cell collection and transplantation in haematological patients: a single centre study from the Rome Transplant Network 49
Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study. 47
Flt3L enhances the early stem cell compartment after ex vivo amplification of umbilical cord blood CD34+ cells. 46
Decreasing impact of relapse on death rate after allogeneic haematopoietic stem cell transplant in patients with chronic myeloid leukaemia: a multi-state modelling study 45
p53 over-expression identifies a subset of nodal peripheral T-cell lymphomas with a distinctive biological profile and poor clinical outcome 44
A prospective molecular study of chimerism in patients with hematologic malignancies receiving unrelated cord blood or bone marrow transplants: detection of mixed chimerism predicts graft failure with or without early autologous reconstitution in cord blood recipients. 43
Transplant Centre Experience and Patient Selection Are the Key Elements Associated with Outcome of RIC and MAC HSCT for CML. 43
P-VABEC: A prospective study of a new weekly chemotherapy regimen for elderly aggressive non Hodgkin Lymphoma 43
DHAP treatment: results of 18 patients with refractory or recurrent non Hodgkin's lymphoma. 43
Risk-assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas. 42
Impiego sequenziale di ARA-C ad alte dosi ed asparaginasi (HIDAC+ASP) nel trattamento di leucemie acute e linfomi maligni in fase avanzata. 42
Decreasing Impact of Relapse on Death Rate after Allogeneic Hematopoietic Stem Cell Transplant in Patients with Chronic Myeloid Leukemia: a multi-state modelling study. 42
Unrelated cord blood transplant (CBT) in patients with high risk leukaemia: a long-term follow-up 41
I linfomi non-Hodgkin 40
A phase III comparative trial of m-BACOD vs m-BNCOD in the treatment of stage II-IV diffuse non-Hodgkin's lymphomas 40
B-cell acute lymphoid leukemia (ALL) with lymphoblastic expressing surface immunoglobulin only at relapse 40
May we predict a “pure” Graft versus Leukemia Effect after Donor Lymphocyte Infusions for chronic myeloid Leukemia relapsing after allogeneic Stem Cell Transplant ? 38
Acute lymphoblastic leukemia (ALL) primary refractory or in first relapse: results in children and adults over a 20-year period 38
Clinical relevance of immunological markers in acute lymphoblastic leukemia. 34
Cord blood transplant (CBT) from unrelated mismatched donor in high risk (HR) leukemia 32
Unrelated cord blood transplant (CBT) in patients with high risk leukemia: A long-term follow-up. 31
Immunophenotype and clinical presentation in T-cell acute lymphoblastic leukemia 31
Determinazione citofluorimetrica del contenuto di DNA cellulare nelle leucemie acute 30
Combination chemotherapy for the treatment of diffuse aggressive lymphomas: F-MACHOP update. 30
Time to relapse has prognistic value in patients with aggressive Lymphoma enrolled onto the Parma trial. 30
Trattamento del linfoma linfoblastico: risultati di due diversi schemi di polichemioterapia intensiva 28
HLA-C and HLA-DQB1 compatibility in unrelated cord blood transplants 27
Aneuploidy determined by flow citometry (FCM) in acute lymphoblastic leukemia (ALL): clinical significance in 99 patients. 26
Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas: experience of the Intergruppo Italiano Linformi. 26
Immunophenotype of adult and childhood acute lymphoblastic leukemia: Changes at 1st relapse and clinico-prognostic implications. 24
Unrelated cord blood transplant (CBT) in patients with high risk leukemia: a long-term follow-up. 24
Outcome of patients developing GVHD after DLI for CML relapse post HSCT: a retrospective study from the CLWP of the EBMT 23
Recombinant alpha interferon in the treatment of low-grade non-Hodgkin's lymphoma: results of a cooperative phase II trial in 31 patients. 23
Three Cases of Therapy-related Acute Myeloid Leukaemia In Patients With Multiple Sclerosis: the Role of Arsenic Trioxide In the Treatment of Secondary Apl 20
THE F-MACHOP REGIMEN IN ADVANCED DIFFUSE AGGRESSIVE LYMPHOMAS - SUMMARY OF 10 YEARS EXPERIENCE AT A SINGLE INSTITUTION 17
The F-MACHOP sequential combination chemotherapy regimen in advanced diffuse aggressive lymphomas: long-term results. 17
Trapianto di sangue da cordone ombelicale (SCO) da donatore non familiare in pazienti con leucemia acuta ad alto rischio 16
Ricerca di unità di sangue di cordone ombellicale (SCO) da donatore non correlato per trapianto allogenico in pazienti affetti da leucemia ad alto rischio 15
Umbilical cord blood (UCB) transplant from unrelated mismatched donor in patients with high risk (HR) leukemia. 14
Il trapianto di cellule staminali da sangue di cordone ombellicale 13
Search for unrelated cord blood (CB) unit for transplantation of high risk leukemic patients 11
Totale 2.687
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.137
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.137
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020521 88 10 1 30 46 85 61 63 49 56 18 14
2020/2021154 30 27 6 13 1 8 0 22 12 19 16 0
2021/2022626 0 33 42 52 98 18 10 58 43 55 68 149
2022/2023703 149 126 47 73 55 114 15 46 50 4 12 12
2023/2024184 24 25 7 9 10 4 5 8 3 34 31 24
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 2.687